Phase I Study of Combination With TBI-1401(HF10), a Replication-competent HSV-1 Oncolytic Virus, and Chemotherapy in Japanese Patients With Stage III or IV Unresectable Pancreatic Cancer.
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2017
At a glance
- Drugs HF 10 (Primary) ; Gemcitabine; Paclitaxel
- Indications Pancreatic cancer
- Focus Adverse reactions
- Sponsors Takara Bio
- 29 Sep 2017 Status changed from not yet recruiting to recruiting.
- 23 Aug 2017 New trial record